Study Summary
This trial will study the effects of a new cancer drug called L-Annamycin. The first part of the trial will focus on finding the best dose of the drug, and the second part will focus on whether the drug can shrink tumors.
- Soft Tissue Sarcoma
- Lung Metastasis
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 2 Secondary · Reporting Duration: Cycle 1 Day 1 ( each cycle is 21 days)
Trial Safety
Safety Progress
Trial Design
1 Treatment Group
Liposomal Annamycin (L-Annamycin)
1 of 1
Experimental Treatment
55 Total Participants · 1 Treatment Group
Primary Treatment: Liposomal Annamycin (L-Annamycin) · No Placebo Group · Phase 1 & 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 14 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Is this pioneering clinical trial a unique endeavor?
"To date, Moleculin Biotech Inc.'s Liposomal Annamycin (L-Annamycin) is only being trialled in 5 cities and 1 country. The initial 2021 drug approval trial was concluded with 55 participants successfully completing the Phase 1 & 2 stages. As of now, a single study has been completed for this medication." - Anonymous Online Contributor
How many sites are conducting this research trial?
"There are a total of 5 sites that are signing up patients for this clinical trial, including the Washington University in Saint Louis, Rutgers Cancer Institute of New Jersey in New Brunswick and Sarcoma Oncology Center in Santa Monica. Additionally, two other locations have been identified as potential recruitment centres." - Anonymous Online Contributor
Has Liposomal Annamycin (L-Annamycin) been utilized in any prior clinical experiments?
"Currently, only one clinical trial is underway for Liposomal Annamycin (L-Annamycin) with none in Phase 3. These studies are predominantly based around Columbus, Ohio but 5 other medical facilities have begun research into this medication." - Anonymous Online Contributor
How many participants have been recruited to join this experiment?
"In order to successfully commence this medical trial, we must enroll 55 qualified participants. Washington University in Saint Louis and Rutgers Cancer Institute of New Jersey are two potential sites for participant recruitment." - Anonymous Online Contributor
Is recruitment underway for this clinical experiment?
"According to the details hosted on clinicaltrials.gov, this trial is currently enrolling participants. The initial posting date was June 5th 2021 and it has been augmented with new information as recently as August 16th 2022." - Anonymous Online Contributor